277 related articles for article (PubMed ID: 34469563)
1. High Prevalence of Vaccine-Type Infections Among Children with Pneumococcal Pneumonia and Effusion After 13-Valent Pneumococcal Conjugate Vaccine Introduction in the Dominican Republic.
Ahmed SS; Lessa FC; Coradin H; Sánchez J; Carvalho MDG; Soda E; Peña C; Fernández J; Cedano D; Whitney CG; Feris-Iglesias J
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S228-S236. PubMed ID: 34469563
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015.
Silva-Costa C; Brito MJ; Pinho MD; Friães A; Aguiar SI; Ramirez M; Melo-Cristino J; ;
Emerg Infect Dis; 2018 Jul; 24(7):1307-1314. PubMed ID: 29912700
[TBL] [Abstract][Full Text] [Related]
3. Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany.
Goettler D; Streng A; Kemmling D; Schoen C; von Kries R; Rose MA; van der Linden M; Liese JG
Vaccine; 2020 Jan; 38(3):570-577. PubMed ID: 31735502
[TBL] [Abstract][Full Text] [Related]
4. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic.
Dunn MG; Lessa FC; Sánchez J; Cordero R; Feris-Iglesias J; Cedano D; Carvalho MDG; Fernández J; Feemster KA
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S237-S247. PubMed ID: 34469551
[TBL] [Abstract][Full Text] [Related]
5. Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018.
Azzari C; Serranti D; Nieddu F; Moriondo M; Casini A; Lodi L; de Benedictis FM; De Vitis E; Cavone F; Cortimiglia M; Indolfi G; Lombardi E; Carloni I; Cutrera R; Lucenteforte E; Resti M; Ricci S
Vaccine; 2019 May; 37(20):2704-2711. PubMed ID: 30981627
[TBL] [Abstract][Full Text] [Related]
6. Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE).
Sando E; Suzuki M; Furumoto A; Asoh N; Yaegashi M; Aoshima M; Ishida M; Hamaguchi S; Otsuka Y; Morimoto K
Vaccine; 2019 May; 37(20):2687-2693. PubMed ID: 30975569
[TBL] [Abstract][Full Text] [Related]
7. Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine.
Syrogiannopoulos GA; Michoula AN; Tsimitselis G; Vassiou K; Chryssanthopoulou DC; Grivea IN
Infect Dis (Lond); 2016 Oct; 48(10):749-53. PubMed ID: 27320108
[TBL] [Abstract][Full Text] [Related]
8. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction.
Njuma Libwea J; Gröndahl-Yli-Hannuksela K; Kobela M; Toropainen M; Nyholm O; Ndombo PK; Koulla-Shiro S; Nohynek H; Nuorti JP; Vuopio J; Palmu AA
Int J Infect Dis; 2020 Sep; 98():113-120. PubMed ID: 32562849
[TBL] [Abstract][Full Text] [Related]
10. Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine era.
Díaz-Conradi A; Hernández S; García-García JJ; Muñoz-Almagro C; Moraga-Llop F; Ciruela P; Izquierdo C; Campins M; de Sevilla MF; González-Peris S; Uriona S; Martínez-Osorio J; Solé-Ribalta A; Codina G; Esteva C; Planes AM; Soldevila N; Salleras L; Domínguez A
Pediatr Pulmonol; 2019 May; 54(5):517-524. PubMed ID: 30784235
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine.
Satzke C; Dunne EM; Choummanivong M; Ortika BD; Neal EFG; Pell CL; Nation ML; Fox KK; Nguyen CD; Gould KA; Hinds J; Chanthongthip A; Xeuatvongsa A; Mulholland EK; Sychareun V; Russell FM
Vaccine; 2019 Jan; 37(2):296-305. PubMed ID: 30502068
[TBL] [Abstract][Full Text] [Related]
12. Continued Vaccine Breakthrough Cases of Serotype 3 Complicated Pneumonia in Vaccinated Children, Portugal (2016-2019).
Silva-Costa C; Gomes-Silva J; Pinho MD; Friães A; Ramirez M; Melo-Cristino J
Microbiol Spectr; 2022 Aug; 10(4):e0107722. PubMed ID: 35862941
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic.
Tomczyk S; Lessa FC; Sánchez J; Peña C; Fernández J; Gloria Carvalho M; Pimenta F; Cedano D; Whitney CG; Verani JR; Coradin H; Garib Z; De Oliveira LH; Feris-Iglesias J
BMC Infect Dis; 2018 Apr; 18(1):152. PubMed ID: 29609548
[TBL] [Abstract][Full Text] [Related]
14. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the National Immunization Program.
Petrović V; Šeguljev Z; Ristić M; Djekić-Malbaša J; Radosavljević B; Medić D; Mihajlović-Ukropina M; Hadnadjev M; Gajic I; Opavski N
Srp Arh Celok Lek; 2016; 144(9-10):521-6. PubMed ID: 29653038
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010-2018.
Ousmane S; Kobayashi M; Seidou I; Issaka B; Sharpley S; Farrar JL; Whitney CG; Ouattara M
Vaccine; 2020 May; 38(23):3922-3929. PubMed ID: 32327220
[TBL] [Abstract][Full Text] [Related]
17. A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine.
Diawara I; Zerouali K; Elmdaghri N; Abid A
BMC Pediatr; 2017 Apr; 17(1):114. PubMed ID: 28449653
[TBL] [Abstract][Full Text] [Related]
18. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
19. The rise and fall of pneumococcal serotypes carried in the PCV era.
Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal serotype evolution in Western Europe.
Tin Tin Htar M; Christopoulou D; Schmitt HJ
BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
